Total Payments
$16,294
2024 Payments
$1,412
Companies
41
Transactions
938
Medicare Patients
192
Medicare Billing
$67,059
Payment Breakdown by Category
Food & Beverage$15,757 (96.7%)
Gifts$506.40 (3.1%)
Education$30.97 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,757 | 934 | 96.7% |
| Gift | $506.40 | 1 | 3.1% |
| Education | $30.97 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,217 | 133 | $0 (2024) |
| USWM, LLC | $1,717 | 72 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,465 | 92 | $0 (2022) |
| ABBVIE INC. | $1,217 | 68 | $0 (2024) |
| Allergan, Inc. | $1,004 | 65 | $0 (2020) |
| ITI, Inc. | $920.76 | 63 | $0 (2023) |
| Lundbeck LLC | $871.88 | 59 | $0 (2024) |
| Alkermes, Inc. | $841.56 | 44 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $803.17 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $652.89 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 80 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($308.45) |
| 2023 | $2,192 | 124 | AbbVie Inc. ($495.31) |
| 2022 | $2,087 | 100 | USWM, LLC ($718.37) |
| 2021 | $2,718 | 155 | Otsuka America Pharmaceutical, Inc. ($538.33) |
| 2020 | $2,638 | 155 | Otsuka America Pharmaceutical, Inc. ($398.33) |
| 2019 | $2,294 | 135 | Otsuka America Pharmaceutical, Inc. ($481.02) |
| 2018 | $1,638 | 107 | Allergan Inc. ($295.53) |
| 2017 | $1,315 | 82 | Sunovion Pharmaceuticals Inc. ($432.38) |
All Payment Transactions
938 individual payment records from CMS Open Payments — Page 4 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: CNS | ||||||
| 01/08/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $9.76 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CNS | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2023 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/13/2023 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/05/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: INSOMNIA | ||||||
| 11/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | USWM, LLC | Lucemyra (Drug), ZIMHI | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2023 | USWM, LLC | Lucemyra (Drug), ZIMHI | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: CNS | ||||||
| 11/10/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 90 | 403 | $61,700 | $33,597 |
| 2022 | 3 | 53 | 169 | $27,100 | $14,843 |
| 2021 | 2 | 32 | 176 | $25,000 | $13,784 |
| 2020 | 1 | 17 | 82 | $8,200 | $4,835 |
Total Patients
192
Total Services
830
Medicare Billing
$67,059
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 186 | $37,200 | $19,606 | 52.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 39 | 203 | $20,300 | $11,530 | 56.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $4,200 | $2,461 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 78 | $15,600 | $8,262 | 53.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 23 | 79 | $7,900 | $4,465 | 56.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,600 | $2,116 | 58.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 74 | $14,800 | $7,804 | 52.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 19 | 102 | $10,200 | $5,980 | 58.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 17 | 82 | $8,200 | $4,835 | 59.0% |
About Dr. Venice Sanchez, M.D
Dr. Venice Sanchez, M.D is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1609004837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Venice Sanchez, M.D has received a total of $16,294 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 938 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($15,757).
As a Medicare-enrolled provider, Sanchez has provided services to 192 Medicare beneficiaries, totaling 830 services with total Medicare billing of $67,059. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Newport Beach, CA
- Active Since 06/25/2009
- Last Updated 07/03/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1609004837
Products in Payments
- VRAYLAR (Drug) $2,173
- REXULTI (Drug) $2,015
- LATUDA (Drug) $1,465
- CAPLYTA (Drug) $1,229
- Lucemyra (Drug) $1,119
- ZIMHI (Drug) $709.69
- ARISTADA (Drug) $616.90
- ABILIFY MYCITE (Drug) $540.54
- Lucemyra/Lofexidine (Drug) $425.41
- APLENZIN (Drug) $418.48
- HETLIOZ (Drug) $391.16
- Trintellix (Drug) $362.17
- Fanapt (Drug) $347.97
- TRINTELLIX (Drug) $344.05
- ABILIFY MAINTENA (Drug) $337.19
- INGREZZA (Drug) $327.77
- INVEGA SUSTENNA (Drug) $304.17
- JORNAY PM (Drug) $274.55
- SPRAVATO (Drug) $235.93
- ADHANSIA XR (Drug) $213.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Psychiatry $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Psychiatry $16,721
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Psychiatry $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Psychiatry $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289
Psychiatry $6,289
Mr. Geoffrey Dibella, M.d, M.D
Psychiatry — Payments: $4,167
Psychiatry $4,167